ConductScience.org, home

Paper4201634

Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.

Greene WH and 4 others. Ann Intern Med, 1973. Cited by 96 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center. Papers, record 4201634. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4201634

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.
PubMed
Journal
Ann Intern Med
PubMed
Year
1973
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
96
iCite
Relative citation ratio, by iCite
4.51
iCite
Revised in PubMed
2019-06-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Greene WHW H
2Moody MM
3Schimpff SS
4Young VMV M
5Wiernik PHP H

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarbenicillinMajor topic
GentamicinsMajor topic
Pseudomonas InfectionsMajor topic
Pseudomonas aeruginosaMajor topic
Agranulocytosis
Cephalothin
Drug Combinations
Enterobacteriaceae
Escherichia coli
Humans
Penicillin Resistance
Proteus mirabilis
Serotyping
Serratia marcescens
Virulence

Source PubMed

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.

PMIDTitleJournalYearIn PapersSource
33,574,807Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review.Front Microbiol2021https://conductscience.org/library/papers/33574807PubMed
15,828,175Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15828175PubMed
7,052,229Prophylactic non-absorbable antibiotics in leukaemic patients.J Hyg (Lond)1980https://conductscience.org/library/papers/7052229PubMed
6,813,351Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.J Clin Microbiol1982https://conductscience.org/library/papers/6813351PubMed
6,766,295Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new).Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6766295PubMed
6,638,994Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6638994PubMed
6,440,473Regrowth of aminoglycoside-resistant variants and its possible implication for determination of MICs.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6440473PubMed
6,436,297Phenotypic factors correlated with the absence of virulence among gentamicin-resistant Pseudomonas aeruginosa strains.J Clin Microbiol1984https://conductscience.org/library/papers/6436297PubMed
6,435,518In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosa.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6435518PubMed
6,372,918The role of the newer beta-lactam antibiotics in the treatment of infection in compromised hosts.Bull N Y Acad Med1984https://conductscience.org/library/papers/6372918PubMed
4,365,671Letter: Gentamicin-resistant escherichia coli.Br Med J1974https://conductscience.org/library/papers/4365671PubMed
4,157,358Comparison of in vitro antibacterial activities of gentamicin and verdamicin.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4157358PubMed
4,157,347Comparison of the in vitro activity of BL-P1654 with gentamicin and carbenicillin against Pseudomonas aeruginosa.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4157347PubMed
4,157,342Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4157342PubMed
3,640,591Antibiotic-resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3640591PubMed
3,300,826Virulence versus resistance.Bull N Y Acad Med1987https://conductscience.org/library/papers/3300826PubMed
3,134,846Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3134846PubMed
1,190,752Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1190752PubMed
1,058,730Infections caused by gram-negative pathogens: new clinical considerations.Bull N Y Acad Med1975https://conductscience.org/library/papers/1058730PubMed
976,132Aminoglycosides: do we need new agents?Drugs1976https://conductscience.org/library/papers/976132PubMed

See all 37 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4201634

GET https://conductscience.org/api/papers/v1/4201634/cited_by?page=2